Intellectual Property Partner Co-Authors InsideCounsel Article on Life Sciences Companies Strategic Decisions Following the Recent Supreme Court Akamai Ruling

In The News
March 15, 2016

An InsideCounsel (subscription required) article by IP rights management partner Melissa Rones (Boston) in the February/March 2016 issue examines how life sciences companies are impacted by the recent Supreme Court and en banc Federal Circuit decisions in Akamai Technologies, Inc. v. Limelight Networks, Inc. The co-authors explain that not only should litigants consider Akamai’s ruling when forming their infringement strategy, but the courts’ decisions and future decisions interpreting its contours will likely have important implications for developing and managing patent portfolios across a range of industries and technologies.